Back to Search Start Over

P1269: VIP152 IS A NOVEL CDK9 INHIBITOR WITH IMPROVED SELECTIVITY, TARGET MODULATION, AND CARDIAC SAFETY IN PATIENTS WITH LYMPHOMA

Authors :
M. Frigault
S. Sher
J. Ravikrishnan
R. Izumi
J. Ware
H. Wong
A. Johnson
B. Stelte-Ludwig
J. Byrd
D. Sampath
K. Rogers
J. Woyach
R. Lapalombella
A. Hamdy
Source :
HemaSphere, Vol 6, Pp 1154-1155 (2022)
Publication Year :
2022
Publisher :
Wiley, 2022.

Details

Language :
English
ISSN :
25729241
Volume :
6
Database :
Directory of Open Access Journals
Journal :
HemaSphere
Publication Type :
Academic Journal
Accession number :
edsdoj.64b3e66bfa824b7dbb3379a1e428acfb
Document Type :
article
Full Text :
https://doi.org/10.1097/01.HS9.0000847940.03718.3d